L. Fairall, “Real-world effectiveness of Ad26.COV2.S or BNT162b2 booster vaccines against severe COVID-19 in adults who received a primary dose of Ad26.COV2.S in South Africa during the Delta period: A retrospective cohort study using medical scheme data”, S Afr Med J, vol. 115, no. 7, p. e2532 , Aug. 2025, doi: 10.7196/SAMJ.2025.v115i7.2532.